BlinkLab Limited (ASX.BB1), a company founded by neuroscientists at Princeton University, over the past several years has fully developed a smartphone based diagnostic platform for autism, ADHD, schizophrenia, and other neurodevelopmental conditions. Our most advanced product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old. This marks a significant advancement, considering traditional diagnoses typically occur around five years of age, often missing the crucial early window for effective intervention. BlinkLab is led by an experienced management team and directors with a proven track record in building companies and vast knowledge in digital healthcare, computer vision, AI and machine learning. Our Scientific Advisory Board consists of leading experts in the field of autism and brain development allowing us to bridge most advanced technological innovations with groundbreaking scientific research.
Company Details
- Employees
- 27
- Founded
- -
- Address
- Oude Delft 37, Delft,zuid-Holland 2611 Bb,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.blinklab.org
- Keywords
- Sydney.
- HQ
- Delft, Zuid-Holland
Blinklab Limited (Asx:bb1) Questions
Blinklab Limited (Asx:Bb1)'s website is https://www.blinklab.org
Blinklab Limited (Asx:Bb1)'s LinkedIn profile is https://www.linkedin.com/company/blinklab-ltd
Blinklab Limited (Asx:Bb1) has
27 employees.
View email and phone details for 27
employees at Blinklab Limited (Asx:Bb1).
Blinklab Limited (Asx:Bb1)'s industry is
Biotechnology Research
Blinklab Limited (Asx:Bb1)'s top competitors are
Bcal Diagnostics,
Atticus Medical,
Purecdm,
Ezz Life Science Holdings Asx:ezz,
Global Pharma Solutions,
Cambium Bio,
Lachesis Biosciences,
Jane Morgan Management (Jmm),
Evithé Biotechnology,
Neuroscientific Biopharmaceuticals Ltd.
Blinklab Limited (Asx:Bb1)'s categories are Biotechnology Research
Blinklab Limited (Asx:Bb1)'s founding year is 2021
